Solventum Stock Outlook: Is Wall Street Bullish or Bearish?
Written by Emily J. Thompson, Senior Investment Analyst
Updated: May 16 2025
0mins
Source: NASDAQ.COM
Company Overview and Stock Performance: Solventum Corporation, a healthcare company based in Minnesota with a market cap of $12.3 billion, has seen its stock outperform the broader market, rising 16.8% over the past year compared to the S&P 500's 11.5% gain. The company reported better-than-expected Q1 2025 results, with sales of $2.1 billion and an adjusted EPS of $1.34.
Analyst Ratings and Future Expectations: Analysts maintain a consensus rating of "Hold" for SOLV stock, with one "Strong Buy," eight "Holds," and one "Strong Sell." Despite expectations of a nearly 16.9% decline in adjusted EPS for fiscal 2025, Solventum has raised its organic sales growth forecast, boosting investor confidence.
Analyst Views on PIPR
Wall Street analysts forecast PIPR stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for PIPR is 386.00 USD with a low forecast of 386.00 USD and a high forecast of 386.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Analyst Rating
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 378.060
Low
386.00
Averages
386.00
High
386.00
Current: 378.060
Low
386.00
Averages
386.00
High
386.00
About PIPR
Piper Sandler Companies is an investment bank and institutional securities firm, serving the needs of corporations, private equity groups, public entities, non-profit entities and institutional investors in the United States and internationally. The Company operates in one segment, providing investment banking services, institutional sales and trading services for various equity and fixed income products, and research services. It provides a broad set of products and services, including financial advisory services; equity and debt capital markets products; public finance services; institutional brokerage services; fundamental equity and macro research services; fixed income services; and alternative asset management strategies. The Company operates alternative asset management funds in merchant banking and healthcare in order to invest firm capital and to manage capital from outside investors. It offers both equity and fixed income advisory and trade execution services.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
